MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AdaptHealth Corp. Market Cap 2011-2026 | AHCO
As of May 01, 2026 AdaptHealth Corp. has a market cap of $ 1.77 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap AdaptHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 B | 1.43 B | 1.36 B | 2.13 B | 2.39 B | 2.01 B | 941 M | 310 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.39 B | 310 M | 1.47 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.71 | 3.18 % | $ 384 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
175 M | $ 25.72 | 0.04 % | $ 217 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.09 | 2.41 % | $ 1.27 M | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.34 | 0.6 % | $ 125 M |  France |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 56.12 | -0.04 % | $ 1.65 B | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 11.24 | 0.54 % | $ 318 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 60.16 | 0.1 % | $ 3.28 B |  Britain |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.65 | 5.74 % | $ 40.5 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.06 | 2.91 % | $ 18 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.36 | 1.96 % | $ 360 M | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.17 | 4.33 % | $ 6.02 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.93 | 2.92 % | $ 1.04 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 301.88 | -4.2 % | $ 115 B | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
TransMedics Group
TMDX
|
4.69 B | $ 99.82 | -0.96 % | $ 3.39 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 19.88 | 1.82 % | $ 1.35 B | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 90.91 | 0.81 % | $ 12.3 B | USA |
 |
NanoVibronix
NAOV
|
92 K | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.73 | 0.19 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.82 | -3.04 % | $ 2.98 B | USA |
 |
Vivos Therapeutics
VVOS
|
15.1 M | $ 0.83 | 3.7 % | $ 8.53 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 83.6 | 0.12 % | $ 48.9 B | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.43 | 3.82 % | $ 64.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.4 | 9.38 % | $ 57 M | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 3.56 | 5.8 % | $ 526 M | USA |